Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

NuVasive Inc Issues FY 2013 Revenue Guidance Above Analysts' Estimates-Conference Call


Wednesday, 9 Jan 2013 08:30am EST 

NuVasive Inc announced that for fiscal 2013, it expects revenue to approximate $655 million. According to I/B/E/S Estimates, analysts are expecting the Company to report revenues of $640 million for fiscal 2013. 

Company Quote

44.1
0.13 +0.30%
26 Nov 2014